InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,051.42
(
-0.21%
)
US TECH 100
17,268.40
(
0.15%
)
Dow Jones
37,798.97
(
0.17%
)
Brent Oil
89.43
(
-0.50%
)
Bitcoin
62,805.33
(
-0.98%
)
Post# of 54907
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

Regenerative

Send PM Follow Ignore
Followers 4
Posts 59
Boards Moderated 0
Alias Born 07/15/2019

Regenerative

Re: None

Friday, 12/20/2019 3:53:27 PM

Friday, December 20, 2019 3:53:27 PM

Post# of 54907
The fda is starting to send letters to all perinatal tissue processors that if they claim cells in their products they are going to be reclassified as a 351 product, meaning it’s a drug. Changing a product to a drug classification is a whole new set of headwinds for these companies. As long as they do not state there are cells in the product and do not make medical claims they will remain a 361. This came from one of my reps today.
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
InvestorsHub NewsWire

FEATURED Cannabix Technologies Begins Certification of Contactless Alcohol Breathalyzer, Re-Brands product series to Breath Logix • Apr 16, 2024 8:52 AM

Maybacks Global Entertainment To Fire Up 24 New Stations in Louisiana • AHRO • Apr 16, 2024 1:30 PM

Kona Gold Beverages, Inc. Acquires Surge Distribution LLC from Loud Beverage Group, Inc. (LBEV) • KGKG • Apr 16, 2024 8:30 AM

Branded Legacy, Inc. Reports Significant Net Income of Over $3.8 Million • BLEG • Apr 16, 2024 8:30 AM

Avant Technologies Begins Development on Next-Generation AI-Driven Resource Allocation Solution • AVAI • Apr 16, 2024 8:00 AM

UC Asset Expected to Report $0.03/share Net Profit for 2023 • UCASU • Apr 11, 2024 10:00 AM

Start posting your company's news
Only $200 per official company press release!